Comparison 2. Etoricoxib (all doses) versus placebo.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Participants with any adverse event	5	1059	Risk Ratio (M‐H, Fixed, 95% CI)	0.91 [0.74, 1.12]